To study the changes in protein in lung cells of Asian patients with advanced non-small cell lung cancer (NSCLC) - PIONEER
Study identifier:D7913L00086
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A molecular epidemiology study in Asian patients with advanced non-small cell lung cancer (NSCLC) of adeno histology to assess epidermal growth factor receptor (EGFR) mutation status
Medical condition
Non Small Cell Lung Cancer
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1270
Study type
Interventional
Age
20 Years +
Date
Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Jul 2011
Study Completion Date: 01 Jul 2011
Study design
Allocation: N/A
Endpoint Classification: N/A
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Screening
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Other: 1 EGFR mutation testing | Procedure/Surgery: Testing for mutation status EGFR mutation test |
Contacts
Investigators
Principal Investigator
Guy Yeoman
AstraZeneca Singapore
